IMAB Historical Balance Sheet

IMAB Stock

USD 1.80 0.01 0.55%

Trend analysis of I Mab balance sheet accounts such as Short and Long Term Debt Total of 85.3 M or Other Current Liab of 459.8 M provides information on I Mab's total assets, liabilities, and equity, which is the actual value of I Mab to its prevalent stockholders. By breaking down trends over time using I Mab balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining I Mab latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether I Mab is a good buy for the upcoming year.

I Mab Inventory

(75.86 Million)

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.

About IMAB Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of I Mab at a specified time, usually calculated after every quarter, six months, or one year. I Mab Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of I Mab and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which IMAB currently owns. An asset can also be divided into two categories, current and non-current.

I Mab Balance Sheet Chart

I Mab Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how I Mab uses and utilizes its capital. It also shows what exactly a company owns and owes.

At present, I Mab's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 85.3 M, whereas Property Plant And Equipment Net is forecasted to decline to about 78.9 M.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Warrants Non Current Liabilities Other

Add Fundamental

Total Assets

Total assets refers to the total amount of I Mab assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in I Mab books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on I Mab balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of I Mab are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Warrants

Securities that give the holder the right to purchase a company's stock at a specified price before a certain date. Warrants are similar to options but are typically issued directly by the company.

Most accounts from I Mab's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into I Mab current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in I Mab. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.

For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.At present, I Mab's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Short and Long Term Debt Total is expected to grow to about 85.3 M, whereas Property Plant And Equipment Net is forecasted to decline to about 78.9 M.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	112.5M	75.0M	53.1M	85.3M
Total Assets	5.6B	4.1B	2.6B	3.7B

Short Long Term Debt Total Total Assets

I Mab balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity
Total Assets		-0.87	0.86	0.85	0.92	0.84	0.72	-0.78	-0.98	-0.57	-0.37	0.99	0.82	-0.82	-0.77	0.99	0.91	-0.22	0.83	0.75	0.18	-0.77	-0.45	0.75	0.77	0.82
Short Long Term Debt Total	-0.87		-0.89	-0.87	-0.75	-0.84	-0.63	0.8	0.93	0.78	0.41	-0.93	-0.54	0.9	0.91	-0.9	-0.69	0.43	-0.89	-0.88	0.2	0.91	0.33	-0.89	-0.46	-0.81
Other Current Liab	0.86	-0.89		0.99	0.69	0.72	0.8	-0.95	-0.89	-0.74	-0.54	0.89	0.59	-0.98	-0.89	0.88	0.69	-0.29	0.81	0.86	0.01	-0.89	-0.21	0.93	0.59	0.73
Total Current Liabilities	0.85	-0.87	0.99		0.65	0.68	0.8	-0.93	-0.87	-0.72	-0.47	0.88	0.56	-0.95	-0.9	0.87	0.65	-0.28	0.77	0.83	0.02	-0.9	-0.14	0.9	0.58	0.69
Total Stockholder Equity	0.92	-0.75	0.69	0.65		0.9	0.68	-0.59	-0.9	-0.52	-0.48	0.9	0.81	-0.68	-0.53	0.92	0.88	-0.18	0.84	0.72	0.25	-0.53	-0.74	0.65	0.7	0.89
Net Tangible Assets	0.84	-0.84	0.72	0.68	0.9		0.73	-0.64	-0.85	-0.81	-0.54	0.86	0.51	-0.75	-0.66	0.86	0.67	-0.55	0.98	0.89	0.13	-0.66	-0.75	0.8	0.37	0.95
Property Plant And Equipment Net	0.72	-0.63	0.8	0.8	0.68	0.73		-0.79	-0.7	-0.77	-0.48	0.71	0.43	-0.76	-0.69	0.75	0.55	-0.28	0.79	0.84	0.51	-0.69	-0.4	0.75	0.47	0.82
Current Deferred Revenue	-0.78	0.8	-0.95	-0.93	-0.59	-0.64	-0.79		0.78	0.72	0.56	-0.78	-0.53	0.95	0.86	-0.79	-0.67	0.35	-0.75	-0.82	-0.11	0.86	0.12	-0.92	-0.56	-0.63
Net Debt	-0.98	0.93	-0.89	-0.87	-0.9	-0.85	-0.7	0.78		0.63	0.37	-1.0	-0.77	0.86	0.82	-0.99	-0.86	0.23	-0.85	-0.8	-0.04	0.82	0.42	-0.79	-0.71	-0.84
Retained Earnings	-0.57	0.78	-0.74	-0.72	-0.52	-0.81	-0.77	0.72	0.63		0.5	-0.64	-0.06	0.77	0.78	-0.64	-0.28	0.73	-0.89	-0.93	-0.03	0.78	0.39	-0.87	-0.01	-0.79
Accounts Payable	-0.37	0.41	-0.54	-0.47	-0.48	-0.54	-0.48	0.56	0.37	0.5		-0.38	-0.31	0.66	0.21	-0.37	-0.39	0.29	-0.55	-0.6	0.04	0.21	0.58	-0.7	-0.21	-0.48
Cash	0.99	-0.93	0.89	0.88	0.9	0.86	0.71	-0.78	-1.0	-0.64	-0.38		0.76	-0.85	-0.83	0.99	0.85	-0.27	0.87	0.8	0.05	-0.83	-0.43	0.8	0.7	0.84
Non Current Assets Total	0.82	-0.54	0.59	0.56	0.81	0.51	0.43	-0.53	-0.77	-0.06	-0.31	0.76		-0.55	-0.39	0.78	0.96	0.27	0.45	0.37	0.21	-0.39	-0.36	0.41	0.97	0.52
Non Currrent Assets Other	-0.82	0.9	-0.98	-0.95	-0.68	-0.75	-0.76	0.95	0.86	0.77	0.66	-0.85	-0.55		0.85	-0.84	-0.67	0.33	-0.82	-0.89	0.08	0.85	0.27	-0.97	-0.53	-0.74
Long Term Debt	-0.77	0.91	-0.89	-0.9	-0.53	-0.66	-0.69	0.86	0.82	0.78	0.21	-0.83	-0.39	0.85		-0.81	-0.55	0.43	-0.76	-0.82	0.08	1.0	0.0	-0.84	-0.41	-0.67
Cash And Short Term Investments	0.99	-0.9	0.88	0.87	0.92	0.86	0.75	-0.79	-0.99	-0.64	-0.37	0.99	0.78	-0.84	-0.81		0.87	-0.26	0.87	0.8	0.16	-0.81	-0.45	0.78	0.73	0.85
Net Receivables	0.91	-0.69	0.69	0.65	0.88	0.67	0.55	-0.67	-0.86	-0.28	-0.39	0.85	0.96	-0.67	-0.55	0.87		0.01	0.64	0.54	0.23	-0.55	-0.43	0.58	0.91	0.65
Good Will	-0.22	0.43	-0.29	-0.28	-0.18	-0.55	-0.28	0.35	0.23	0.73	0.29	-0.27	0.27	0.33	0.43	-0.26	0.01		-0.61	-0.5	0.07	0.43	0.3	-0.55	0.36	-0.37
Common Stock Total Equity	0.83	-0.89	0.81	0.77	0.84	0.98	0.79	-0.75	-0.85	-0.89	-0.55	0.87	0.45	-0.82	-0.76	0.87	0.64	-0.61		0.94	0.11	-0.76	-0.63	0.88	0.35	0.94
Common Stock Shares Outstanding	0.75	-0.88	0.86	0.83	0.72	0.89	0.84	-0.82	-0.8	-0.93	-0.6	0.8	0.37	-0.89	-0.82	0.8	0.54	-0.5	0.94		0.05	-0.82	-0.48	0.93	0.31	0.91
Short Term Investments	0.18	0.2	0.01	0.02	0.25	0.13	0.51	-0.11	-0.04	-0.03	0.04	0.05	0.21	0.08	0.08	0.16	0.23	0.07	0.11	0.05		0.08	-0.26	-0.07	0.31	0.22
Long Term Debt Total	-0.77	0.91	-0.89	-0.9	-0.53	-0.66	-0.69	0.86	0.82	0.78	0.21	-0.83	-0.39	0.85	1.0	-0.81	-0.55	0.43	-0.76	-0.82	0.08		0.0	-0.84	-0.41	-0.67
Non Current Liabilities Total	-0.45	0.33	-0.21	-0.14	-0.74	-0.75	-0.4	0.12	0.42	0.39	0.58	-0.43	-0.36	0.27	0.0	-0.45	-0.43	0.3	-0.63	-0.48	-0.26	0.0		-0.34	-0.18	-0.7
Capital Surpluse	0.75	-0.89	0.93	0.9	0.65	0.8	0.75	-0.92	-0.79	-0.87	-0.7	0.8	0.41	-0.97	-0.84	0.78	0.58	-0.55	0.88	0.93	-0.07	-0.84	-0.34		0.36	0.75
Other Current Assets	0.77	-0.46	0.59	0.58	0.7	0.37	0.47	-0.56	-0.71	-0.01	-0.21	0.7	0.97	-0.53	-0.41	0.73	0.91	0.36	0.35	0.31	0.31	-0.41	-0.18	0.36		0.42
Other Stockholder Equity	0.82	-0.81	0.73	0.69	0.89	0.95	0.82	-0.63	-0.84	-0.79	-0.48	0.84	0.52	-0.74	-0.67	0.85	0.65	-0.37	0.94	0.91	0.22	-0.67	-0.7	0.75	0.42

Click cells to compare fundamentals

I Mab Account Relationship Matchups

I Mab balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.7B	6.3B	5.6B	4.1B	2.6B	3.7B
Short Long Term Debt Total	132.5M	13.6M	112.5M	75.0M	53.1M	85.3M
Other Current Liab	531.7M	560.6M	593.3M	608.1M	381.8M	459.8M
Total Current Liabilities	588.5M	576.1M	624.0M	659.7M	411.8M	534.5M
Total Stockholder Equity	(2.0B)	5.6B	4.6B	3.0B	1.7B	1.8B
Other Liab	2.5M	3.9M	125.0M	335.8M	386.2M	405.5M
Net Tangible Assets	(1.3B)	(2.3B)	5.3B	4.3B	5.0B	5.2B
Property Plant And Equipment Net	46.5M	40.3M	158.5M	124.0M	82.9M	78.9M
Current Deferred Revenue	3.9M	7.5M	2.4M	8.7M	7.8M	7.0M
Net Debt	(1.0B)	(4.7B)	(3.4B)	(3.1B)	(2.1B)	(2.2B)
Retained Earnings	(2.5B)	(2.0B)	(4.4B)	(6.8B)	(8.3B)	(7.9B)
Cash	1.1B	4.8B	3.5B	3.2B	2.1B	2.6B
Non Current Assets Total	376.3M	990.1M	847.7M	447.2M	276.3M	262.5M
Non Currrent Assets Other	18.3M	2.0M	26.6M	10.9M	63.2M	90.7M
Cash And Short Term Investments	1.2B	4.8B	4.3B	3.4B	2.3B	2.9B
Net Receivables	55.9M	553.4M	477.7M	80.3M	92.3M	87.7M
Common Stock Shares Outstanding	57.8M	68.4M	76.0M	82.5M	88.7M	72.7M
Short Term Investments	32M	31.5M	753.2M	235.4M	143.2M	269.9M
Liabilities And Stockholders Equity	1.7B	6.3B	5.6B	4.1B	2.6B	3.7B
Non Current Liabilities Total	3.2B	130.5M	417.6M	405.6M	483.0M	458.8M
Capital Lease Obligations	14.3M	13.6M	112.5M	56.0M	64.4M	36.0M
Inventory	(55.9M)	(422.9M)	27.2M	(80.3M)	(72.3M)	(75.9M)
Other Current Assets	191.8M	422.9M	444.6M	177.0M	52.0M	49.4M
Other Stockholder Equity	(2.7B)	7.7B	9.1B	9.6B	9.7B	5.3B
Total Liab	3.8B	706.6M	1.0B	1.1B	894.8M	1.4B
Net Invested Capital	(1.9B)	5.6B	4.6B	3.0B	3.5B	1.9B
Property Plant And Equipment Gross	46.5M	40.3M	158.5M	124.0M	142.6M	76.9M
Total Current Assets	1.4B	5.3B	4.8B	3.6B	2.3B	3.2B
Accumulated Other Comprehensive Income	70.1M	(50.8M)	(186.5M)	216.7M	298.3M	313.2M
Net Working Capital	772.8M	4.8B	4.2B	3.0B	3.4B	2.7B
Short Term Debt	56.8M	8.1M	30.7M	42.9M	30.0M	39.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether I Mab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of I Mab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of I Mab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on I Mab Stock:

How To Invest In IMAB

Details

Is IMAB Stock a good investment?

Details

What is I Mab's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

For information on how to trade IMAB Stock refer to our How to Trade IMAB Stock guide.

Note that the I Mab information on this page should be used as a complementary analysis to other I Mab's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for IMAB Stock analysis

When running I Mab's price analysis, check to measure I Mab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy I Mab is operating at the current time. Most of I Mab's value examination focuses on studying past and present price action to predict the probability of I Mab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move I Mab's price. Additionally, you may evaluate how the addition of I Mab to your portfolios can decrease your overall portfolio volatility.

	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Stocks Directory Find actively traded stocks across global markets
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes

Is I Mab's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of I Mab. If investors know IMAB will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about I Mab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(3.72)

Revenue Per Share

0.312

Quarterly Revenue Growth

(0.62)

Return On Assets

(0.23)

Return On Equity

(0.62)

The market value of I Mab is measured differently than its book value, which is the value of IMAB that is recorded on the company's balance sheet. Investors also form their own opinion of I Mab's value that differs from its market value or its book value, called intrinsic value, which is I Mab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because I Mab's market value can be influenced by many factors that don't directly affect I Mab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between I Mab's value and its price as these two are different measures arrived at by different means. Investors typically determine if I Mab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, I Mab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IMAB Historical Balance Sheet

I Mab Inventory

(75.86 Million)

About IMAB Balance Sheet Analysis

I Mab Balance Sheet Chart

Total Assets

Total Current Liabilities

Warrants

I Mab balance sheet Correlations

I Mab Account Relationship Matchups

High Positive Relationship

High Negative Relationship

I Mab balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for IMAB Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Accumulated Amortization	Total Assets
Short Long Term Debt Total	Other Current Liab
Total Current Liabilities	Total Stockholder Equity
Other Liab	Net Tangible Assets
Property Plant And Equipment Net	Total Permanent Equity
Warrants	Current Deferred Revenue
Noncontrolling Interest In Consolidated Entity	Net Debt
Retained Earnings	Accounts Payable
Cash	Non Current Assets Total
Non Currrent Assets Other	Other Assets
Long Term Debt	Cash And Short Term Investments
Net Receivables	Good Will
Common Stock Total Equity	Retained Earnings Total Equity
Common Stock Shares Outstanding	Short Term Investments
Long Term Debt Total	Liabilities And Stockholders Equity
Non Current Liabilities Total	Capital Surpluse
Capital Lease Obligations	Negative Goodwill
Inventory	Other Current Assets
Other Stockholder Equity	Total Liab
Additional Paid In Capital	Deferred Long Term Liab
Net Invested Capital	Preferred Stock Redeemable
Long Term Investments	Property Plant And Equipment Gross
Short Long Term Debt	Preferred Stock Total Equity
Total Current Assets	Accumulated Other Comprehensive Income
Treasury Stock	Non Current Liabilities Other
Accumulated Depreciation	Net Working Capital
Deferred Long Term Asset Charges	Short Term Debt
Intangible Assets	Common Stock
Temporary Equity Redeemable Noncontrolling Interests	Property Plant Equipment
Capital Stock

Long Term Debt Total	+ 1.0	Long Term Debt
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab
Cash And Short Term Investments	+ 0.99	Cash
Common Stock Total Equity	+ 0.98	Net Tangible Assets

Cash	- 1.0	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Non Currrent Assets Other	- 0.98	Other Current Liab
Net Debt	- 0.98	Total Assets
Capital Surpluse	- 0.97	Non Currrent Assets Other
Non Currrent Assets Other	- 0.95	Total Current Liabilities